OSI Pharmaceuticals Overview

  • Founded
  • 1983
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 557
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2
  • Investments
  • 4

OSI Pharmaceuticals General Information

Description

Manufacturer and seller of cancer medicines. The company engages in discovering, developing and commercialization of molecular targeted therapies used in oncology, diabetes and obesity disease. It also manufactures and sells cancer medicine Tarceva.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Astellas Pharma
Primary Office
  • 41 Pinelawn Road
  • Melville, NY 11747
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OSI Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OSI Pharmaceuticals‘s full profile, request access.

Request a free trial

OSI Pharmaceuticals Executive Team (4)

Name Title Board Seat Contact Info
Neil Gibson Ph.D Chief Scientific Officer
To view OSI Pharmaceuticals’s complete executive team members history, request access »

OSI Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OSI Pharmaceuticals Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 25-Jun-2009 000000000 0000 Biotechnology
0000000 0000000000 14-Nov-2005 000000000000000000 00000 Pharmaceuticals
0000 00000000 12-Jun-2003 000000000000000000 0000 Biotechnology
Gilead Sciences (Oncology Assets) 26-Nov-2001 Corporate Asset Purchase 00000 Buildings and Property 00000 0000000 00.0
To view OSI Pharmaceuticals’s complete investments and acquisitions history, request access »

OSI Pharmaceuticals Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 00000000 25-Jun-2009 000000000 0000 Completed
  • 000 00000000000000
Eyetech Pharmaceuticals 14-Nov-2005 Merger/Acquisition 00000 Completed
To view OSI Pharmaceuticals’s complete exits history, request access »